Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information

Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of clinical and laboratory investigation 1987-06, Vol.47 (4), p.325-329
Hauptverfasser: PANTEGHINI, M, CALARCO, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 329
container_issue 4
container_start_page 325
container_title Scandinavian journal of clinical and laboratory investigation
container_volume 47
creator PANTEGHINI, M
CALARCO, M
description Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3 reaches a peak first, 17 h after infarction (394 U/l), followed by MB2 (17.3 h, 190 U/l), MB1 (20.6 h, 82 U/l), MM2 (28.7 h, 637 U/l), and MM1 (32 h, 780 U/l). According to their faster decay from circulation, MB2 and MM3 have higher fractional disappearance rates (-0.035 and -0.026 per hour, respectively). The MM3/MM1 activity ratio rises beyond the upper limit found in healthy subjects within about 3 h after onset of symptoms and peaks 9.3 h after AMI, even earlier than peaks of isoforms. These characteristics make the ratio an earlier and more sensitive indicator of acute enzyme release from necrotic myocardium.
doi_str_mv 10.3109/00365518709168909
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77608641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77608641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c257t-ca2a8d789362e4459dd0565392923483ee5e685146aedfdcd99ac21959eeacdd3</originalsourceid><addsrcrecordid>eNplkc9u1DAQhy1EVZa2D8AByQfUEyn-Ezv2sVQFKnXFAXqOpvaEGhI7tROkfQpeGS9d9cLJGn-_-Ub2EPKGswvJmf3AmNRKcdMxy7WxzL4gG66YaDpt9Euy2fOmBuQr8rqUn6zW0rTH5FhqJiznG_LnG-Z1oqGkIeWp0DRQlxGWEJH-ChEK0u2WQvR0-5GGSKddcpB9gLFWA2S3hBQv6GWkMM8ZQqmgOh5XiEtYquc3vqduDDG4SvaeGZaHND_sSkhj-vHvuprqcNirTsnRAGPBs8N5Qu4-XX-_-tLcfv18c3V52zihuqVxIMD4zlipBbatst4zpZW0wgrZGomoUBvFWw3oB--8teAEt8oigvNenpDzJ--c0-OKZemnUByOI0RMa-m7TjOjW16D_Cnociol49DPOUyQdz1n_X4J_X9LqD1vD_L1fkL_3HH49crfHTiU-v4hQ3ShPMe6VtRcJ_8CBySQ7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77608641</pqid></control><display><type>article</type><title>Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information</title><source>MEDLINE</source><source>Taylor &amp; Francis:Master (3349 titles)</source><source>Taylor &amp; Francis Medical Library - CRKN</source><creator>PANTEGHINI, M ; CALARCO, M</creator><creatorcontrib>PANTEGHINI, M ; CALARCO, M</creatorcontrib><description>Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3 reaches a peak first, 17 h after infarction (394 U/l), followed by MB2 (17.3 h, 190 U/l), MB1 (20.6 h, 82 U/l), MM2 (28.7 h, 637 U/l), and MM1 (32 h, 780 U/l). According to their faster decay from circulation, MB2 and MM3 have higher fractional disappearance rates (-0.035 and -0.026 per hour, respectively). The MM3/MM1 activity ratio rises beyond the upper limit found in healthy subjects within about 3 h after onset of symptoms and peaks 9.3 h after AMI, even earlier than peaks of isoforms. These characteristics make the ratio an earlier and more sensitive indicator of acute enzyme release from necrotic myocardium.</description><identifier>ISSN: 0036-5513</identifier><identifier>EISSN: 1502-7686</identifier><identifier>DOI: 10.3109/00365518709168909</identifier><identifier>PMID: 3602911</identifier><identifier>CODEN: SJCLAY</identifier><language>eng</language><publisher>Oslo: Scandinavian University Press</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Cardiology. Vascular system ; Coronary heart disease ; Creatine Kinase - blood ; Female ; Heart ; Humans ; Isoenzymes ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - enzymology ; Myocardial Infarction - physiopathology ; Prognosis</subject><ispartof>Scandinavian journal of clinical and laboratory investigation, 1987-06, Vol.47 (4), p.325-329</ispartof><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c257t-ca2a8d789362e4459dd0565392923483ee5e685146aedfdcd99ac21959eeacdd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7420297$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3602911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PANTEGHINI, M</creatorcontrib><creatorcontrib>CALARCO, M</creatorcontrib><title>Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information</title><title>Scandinavian journal of clinical and laboratory investigation</title><addtitle>Scand J Clin Lab Invest</addtitle><description>Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3 reaches a peak first, 17 h after infarction (394 U/l), followed by MB2 (17.3 h, 190 U/l), MB1 (20.6 h, 82 U/l), MM2 (28.7 h, 637 U/l), and MM1 (32 h, 780 U/l). According to their faster decay from circulation, MB2 and MM3 have higher fractional disappearance rates (-0.035 and -0.026 per hour, respectively). The MM3/MM1 activity ratio rises beyond the upper limit found in healthy subjects within about 3 h after onset of symptoms and peaks 9.3 h after AMI, even earlier than peaks of isoforms. These characteristics make the ratio an earlier and more sensitive indicator of acute enzyme release from necrotic myocardium.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Coronary heart disease</subject><subject>Creatine Kinase - blood</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Isoenzymes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - enzymology</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Prognosis</subject><issn>0036-5513</issn><issn>1502-7686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkc9u1DAQhy1EVZa2D8AByQfUEyn-Ezv2sVQFKnXFAXqOpvaEGhI7tROkfQpeGS9d9cLJGn-_-Ub2EPKGswvJmf3AmNRKcdMxy7WxzL4gG66YaDpt9Euy2fOmBuQr8rqUn6zW0rTH5FhqJiznG_LnG-Z1oqGkIeWp0DRQlxGWEJH-ChEK0u2WQvR0-5GGSKddcpB9gLFWA2S3hBQv6GWkMM8ZQqmgOh5XiEtYquc3vqduDDG4SvaeGZaHND_sSkhj-vHvuprqcNirTsnRAGPBs8N5Qu4-XX-_-tLcfv18c3V52zihuqVxIMD4zlipBbatst4zpZW0wgrZGomoUBvFWw3oB--8teAEt8oigvNenpDzJ--c0-OKZemnUByOI0RMa-m7TjOjW16D_Cnociol49DPOUyQdz1n_X4J_X9LqD1vD_L1fkL_3HH49crfHTiU-v4hQ3ShPMe6VtRcJ_8CBySQ7w</recordid><startdate>19870601</startdate><enddate>19870601</enddate><creator>PANTEGHINI, M</creator><creator>CALARCO, M</creator><general>Scandinavian University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19870601</creationdate><title>Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information</title><author>PANTEGHINI, M ; CALARCO, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c257t-ca2a8d789362e4459dd0565392923483ee5e685146aedfdcd99ac21959eeacdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Coronary heart disease</topic><topic>Creatine Kinase - blood</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Isoenzymes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - enzymology</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PANTEGHINI, M</creatorcontrib><creatorcontrib>CALARCO, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PANTEGHINI, M</au><au>CALARCO, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information</atitle><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle><addtitle>Scand J Clin Lab Invest</addtitle><date>1987-06-01</date><risdate>1987</risdate><volume>47</volume><issue>4</issue><spage>325</spage><epage>329</epage><pages>325-329</pages><issn>0036-5513</issn><eissn>1502-7686</eissn><coden>SJCLAY</coden><abstract>Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3 reaches a peak first, 17 h after infarction (394 U/l), followed by MB2 (17.3 h, 190 U/l), MB1 (20.6 h, 82 U/l), MM2 (28.7 h, 637 U/l), and MM1 (32 h, 780 U/l). According to their faster decay from circulation, MB2 and MM3 have higher fractional disappearance rates (-0.035 and -0.026 per hour, respectively). The MM3/MM1 activity ratio rises beyond the upper limit found in healthy subjects within about 3 h after onset of symptoms and peaks 9.3 h after AMI, even earlier than peaks of isoforms. These characteristics make the ratio an earlier and more sensitive indicator of acute enzyme release from necrotic myocardium.</abstract><cop>Oslo</cop><pub>Scandinavian University Press</pub><pmid>3602911</pmid><doi>10.3109/00365518709168909</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-5513
ispartof Scandinavian journal of clinical and laboratory investigation, 1987-06, Vol.47 (4), p.325-329
issn 0036-5513
1502-7686
language eng
recordid cdi_proquest_miscellaneous_77608641
source MEDLINE; Taylor & Francis:Master (3349 titles); Taylor & Francis Medical Library - CRKN
subjects Adult
Aged
Biological and medical sciences
Cardiology. Vascular system
Coronary heart disease
Creatine Kinase - blood
Female
Heart
Humans
Isoenzymes
Male
Medical sciences
Middle Aged
Myocardial Infarction - enzymology
Myocardial Infarction - physiopathology
Prognosis
title Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T00%3A14%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20isoforms%20of%20creatine%20kinase%20MM%20and%20MB%20in%20myocardial%20infarction.%20An%20appraisal%20of%20quantitative,%20clinical%20and%20pathophysiological%20information&rft.jtitle=Scandinavian%20journal%20of%20clinical%20and%20laboratory%20investigation&rft.au=PANTEGHINI,%20M&rft.date=1987-06-01&rft.volume=47&rft.issue=4&rft.spage=325&rft.epage=329&rft.pages=325-329&rft.issn=0036-5513&rft.eissn=1502-7686&rft.coden=SJCLAY&rft_id=info:doi/10.3109/00365518709168909&rft_dat=%3Cproquest_cross%3E77608641%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77608641&rft_id=info:pmid/3602911&rfr_iscdi=true